$ARIA Headlines Six stocks to watch 4:27 p.m.
Post# of 88933
Posted On: 07/21/2014 11:34:27 AM
$ARIA Headlines
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Is Now the Time to Buy Stocks in Space Exploration Technology? 10:50 p.m. July 17, 2014 - InvestorPlace.com
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market 11:40 a.m. July 16, 2014 - TheStreet.com
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation 4:19 p.m. July 15, 2014 - TheStreet.com
ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure in Europe 6:36 a.m. July 14, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AUXL OPK ARIA MNKD 1:30 p.m. July 11, 2014 - InvestorPlace.com
ARIAD Pharmaceuticals (ARIA) Is Water-Logged And Getting Wetter Today 10:39 a.m. July 8, 2014 - TheStreet.com
UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog 6:10 p.m. July 7, 2014 - Zacks.com
OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog 4:30 p.m. July 7, 2014 - Zacks.com
Why A Short Covering Rally Might Come for Ariad Pharmaceuticals (ARIA) Stock - Tale of the Tape 8:42 a.m. July 7, 2014 - Zacks.com
Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape 9:46 a.m. July 3, 2014 - Zacks.com
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape 8:51 a.m. July 3, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape 9:46 a.m. July 2, 2014 - Zacks.com
Karyopharm Therapeutics (KPTI) in Focus: Stock Goes Down 5.2% - Tale of the Tape 8:59 a.m. July 2, 2014 - Zacks.com
Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session - Tale of the Tape 8:51 a.m. July 2, 2014 - Zacks.com
IGI Laboratories (IG) Worth Watching: Stock Rises 6.2% - Tale of the Tape 9:25 a.m. July 1, 2014 - Zacks.com
Auxilium Pharmaceuticals (AUXL) Crumbles: Stock Falls by 5.6% - Tale of the Tape 8:59 a.m. July 1, 2014 - Zacks.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 11:50 a.m. June 30, 2014 - Zacks.com
Pacira's Exparel Positive in Phase IV Studies - Analyst Blog 11:30 a.m. June 27, 2014 - Zacks.com
QLT Inc. (QLTI) in Focus: Stock Surges 14.63% - Tale of the Tape 8:44 a.m. June 27, 2014 - Zacks.com
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 7:35 a.m. July 16, 2014 - BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe 7:35 a.m. July 14, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:01 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:16 p.m. May 31, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences 7:36 a.m. May 28, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:16 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:36 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:36 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:36 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
6 stocks to watch 4:34 p.m. Feb. 12, 2014 - The Trading Deck
Ariad falls after wild ride upward, while Care.com holds on to its gains 10:02 p.m. Jan. 27, 2014 - Russ Britt
Apple green ahead of earnings; Caterpillar tops gainers 4:42 p.m. Jan. 27, 2014 - Sue Chang
Ariad shares jump nearly 30% on rumors of Big Pharma takeover 2:43 p.m. Jan. 24, 2014 - Russ Britt
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
Apple closes lower; B. of A. rises on analyst call 5:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 4:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 7:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 4:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 9:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 1:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 4:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 11:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 8:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 8:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 11:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 4:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 11:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 2:06 p.m. Dec. 14, 2012 - MarketWatch.com
Is Now the Time to Buy Stocks in Space Exploration Technology? 10:50 p.m. July 17, 2014 - InvestorPlace.com
Yellen, Icahn Comments Put a Lid on Small-Cap Stocks, May Hurt Larger Market 11:40 a.m. July 16, 2014 - TheStreet.com
Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation 4:19 p.m. July 15, 2014 - TheStreet.com
ARIAD Announces Continuation of Iclusig Review Related to Article 20 Procedure in Europe 6:36 a.m. July 14, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AUXL OPK ARIA MNKD 1:30 p.m. July 11, 2014 - InvestorPlace.com
ARIAD Pharmaceuticals (ARIA) Is Water-Logged And Getting Wetter Today 10:39 a.m. July 8, 2014 - TheStreet.com
UCB, Dermira Sign Cimzia Dermatology Deal - Analyst Blog 6:10 p.m. July 7, 2014 - Zacks.com
OncoGenex's Apatorsen in Phase II for Lung Cancer - Analyst Blog 4:30 p.m. July 7, 2014 - Zacks.com
Why A Short Covering Rally Might Come for Ariad Pharmaceuticals (ARIA) Stock - Tale of the Tape 8:42 a.m. July 7, 2014 - Zacks.com
Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape 9:46 a.m. July 3, 2014 - Zacks.com
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape 8:51 a.m. July 3, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape 9:46 a.m. July 2, 2014 - Zacks.com
Karyopharm Therapeutics (KPTI) in Focus: Stock Goes Down 5.2% - Tale of the Tape 8:59 a.m. July 2, 2014 - Zacks.com
Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session - Tale of the Tape 8:51 a.m. July 2, 2014 - Zacks.com
IGI Laboratories (IG) Worth Watching: Stock Rises 6.2% - Tale of the Tape 9:25 a.m. July 1, 2014 - Zacks.com
Auxilium Pharmaceuticals (AUXL) Crumbles: Stock Falls by 5.6% - Tale of the Tape 8:59 a.m. July 1, 2014 - Zacks.com
UCB's Vimpat Positive for Partial-Onset Seizures - Analyst Blog 11:50 a.m. June 30, 2014 - Zacks.com
Pacira's Exparel Positive in Phase IV Studies - Analyst Blog 11:30 a.m. June 27, 2014 - Zacks.com
QLT Inc. (QLTI) in Focus: Stock Surges 14.63% - Tale of the Tape 8:44 a.m. June 27, 2014 - Zacks.com
ARIAD to Webcast Conference Call on Second Quarter 2014 Financial Results 7:35 a.m. July 16, 2014 - BusinessWire - BZX
ARIAD Announces Continuation of Iclusig Review under the Article 20 Procedure in Europe 7:35 a.m. July 14, 2014 - BusinessWire - BZX
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
ARIAD Announces Three Key Appointments to Its Global Management Team 7:35 a.m. June 23, 2014 - BusinessWire - BZX
ARIAD Announces Pricing of $200 Million Offering of 3.625% Convertible Senior Notes Due 2019 9:15 a.m. June 12, 2014 - BusinessWire - BZX
ARIAD Announces Proposed $175 Million Offering of Convertible Senior Notes Due 2019 4:01 p.m. June 11, 2014 - BusinessWire - BZX
ARIAD Announces Webcast of Its Annual Shareholders Meeting 7:35 a.m. June 11, 2014 - BusinessWire - BZX
Cohera Medical, Inc.® Appoints Richard W. Pascoe to its Board of Directors 6:00 a.m. June 4, 2014 - PR Newswire - PRF
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors 9:01 a.m. June 1, 2014 - BusinessWire - BZX
ARIAD Presents Updated Phase 1/2 Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer 2:16 p.m. May 31, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 7:10 a.m. May 30, 2014 - PR Newswire - PRF
ARIAD to Present at Upcoming Investor Conferences 7:36 a.m. May 28, 2014 - BusinessWire - BZX
Clinical Trial Results, Development Collaboration, Board Appointments, Presentations, and Quarterly Results - Analyst Notes on Gilead, Questcor, Vertex, ARIAD and Puma Biotechnology 7:40 a.m. May 20, 2014 - PR Newswire - PRF
ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2014 ASCO Annual Meeting 5:16 p.m. May 14, 2014 - BusinessWire - BZX
ARIAD to Present at UBS Global Healthcare Conference 7:36 a.m. May 13, 2014 - BusinessWire - BZX
ARIAD Reports First Quarter 2014 Financial Results and Development Progress 7:36 a.m. May 7, 2014 - BusinessWire - BZX
Active Stocks at a Glance -- Research on American Airlines, American Capital Agency, Akamai Technologies, and ARIAD Pharma 12:24 p.m. May 5, 2014 - PR Newswire - PRF
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results 7:36 a.m. April 16, 2014 - BusinessWire - BZX
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, Jazz, Ariad, and BioMarin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼